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Abstract: Previous studies on cognitive training in Alzheimer’s disease (AD) were principally 
aimed at making patients learn items not related to functional needs. However, AD patients 
also experience difﬁ  culties with instrumental activities of daily living (IADL). The goal of the 
present multiple baseline case report study was to assess the preliminary efﬁ  cacy and toler-
ability of an individualized cognitive training program using the errorless learning (EL) and 
spaced-retrieval (SR) techniques to relearn forgotten IADLs in mild AD. Following an exhaustive 
neuropsychological assessment, two participants received two training sessions per week during 
four weeks. Participant A was trained to use his voice mail and Participant B, to manage the 
messages from his answering machine. The results showed that the program was well tolerated 
and improved performance on the trained tasks. These ameliorations were maintained over a 
5-week period. The effects of the training did not have any impact on global cognitive functions 
since the results on these measures remained relatively stable. This case report demonstrated 
preliminary efﬁ  cacy of a new cognitive training program using EL and SR techniques tailored 
to the needs of AD patients. This is an important ﬁ  nding since the loss of these capacities alters 
autonomy in AD patients.
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Introduction
The prevalence of Alzheimer disease (AD) will increase considerably in the next 
decades in industrialized countries because of their aging populations. In the USA, 
there were 4.5 million Americans affected by AD in 2000, and it is estimated that this 
number will increase 3-fold by 2050 (Hebert et al 2003). In Canada, the prevalence 
estimates of the Canadian Study of Health and Aging suggest that 314,000 Canadians 
will present with AD in 2011 (Canadian Study of Health and Aging 1994). Current 
estimates indicate that 24 million individuals in the world present with dementia, and 
it is predicted that this number will double every 20 years (Qiu et al 2007).
At the moment, there is no cure for AD. However, several approaches are now 
available for the symptomatic treatment of AD. Cholinesterase inhibitors (ie, donepezil, 
rivastigmine, and galantamine) are effective to maintain cognitive abilities and to slow 
down cognitive and functional deteriorations in mild to moderate AD (Birks et al 
2000; Birks and Harvey 2006; Loy and Schneider 2006; Simard and Sampson 2008). 
However, the pharmacological approach presents certain limitations (Evans et al 2004). 
Some patients do not respond to these compounds. It is difﬁ  cult to know when to start, 
when to switch and when to stop treatment, and it may be hard to get the appropriate 
dose. Side effects, adverse events, and drug interactions may also occur. In addition, 
the costs are important for the patients and society (Evans et al 2004). For all these 
reasons, alternative treatment strategies were developed over the past ﬁ  fteen years.Neuropsychiatric Disease and Treatment 2008:4(5) 988
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Cognitive training is among these strategies. A recent 
meta-analysis looked at over 17 controlled studies on cogni-
tive training in AD, and concluded that this nonpharmaco-
logical approach is effective for improving cognition and 
function in AD (Sitzer et al 2006). In a systematic review 
of the literature, Grandmaison and Simard (2003) analyzed 
17 studies on cognitive training in order to target techniques 
demonstrating some efﬁ  cacy in AD. These authors con-
cluded that the errorless learning (EL) technique, which 
supports the encoding of new material, and the spaced-
retrieval (SP) technique, which supports the recall of new 
learned material, were the most promising paradigms for 
training memory in AD. This conclusion was supported by 
another literature review (Bier et al 2006) that identiﬁ  ed EL 
and SR as two out of three techniques to utilize for cognitive 
training in AD, the third method being the vanishing cues. 
Brieﬂ  y, the EL aims at reducing errors to a minimum during 
learning (Baddeley and Wilson 1994), whereas in the SR 
technique, the recall of the information is done by gradually 
increasing the delay between each correct recall (Camp et al 
1996). The superiority of the EL technique over the errorful 
technique was recently demonstrated by Metzler-Baddeley 
and Snowden (2005), in four patients with AD, on tasks 
involving to relearn material that was previously familiar 
to the patients, and to learn new information. In another 
study, 25 patients with AD who received cognitive training 
registered statistically signiﬁ  cant improvements compared 
to 19 control patients who received mental stimulation 
only (Loewenstein et al 2004). The gains were observed 
on the performance of cognitive tasks (ie, recall of face-
name associations, orientation, cognitive processing speed) 
and on the performance of functional tasks (ie, making 
change for a purchase) that were trained using the SR and 
other cognitive techniques such as dual cognitive support, 
procedural-memory activation, visuo-motor processing acti-
vation, and functional skills training. More recently, the EL 
and SR techniques used in combination to relearn forgotten 
names of celebrities and to learn new names showed some 
success with performances from 20% to 100% and from 
0% to 100% in two patients with amnestic mild cognitive 
impairment (A-MCI) (Jean et al 2007). These results suggest 
that these two techniques used in combination are effective 
to learn and relearn episodic and semantic information in 
A-MCI patients. These patients are considered to be in an 
intermediate state between normal aging and early dementia 
(Petersen 2004).
Some authors criticized the fact that previous studies used 
multiple cognitive techniques to train the AD patients (often 
more than three), making it hard to determine the relative 
efﬁ  cacy of each of them, and that only a few studies used 
performance-based measures of daily living functions or 
direct measures of the task to be trained (Grandmaison and 
Simard 2003; Sitzer et al 2006). The majority of previous 
studies on cognitive training in AD were principally aimed 
at making patients learn items not related to functional tasks. 
However, AD patients with mild-to-moderate dementia also 
experience difﬁ  culties with instrumental activities of daily 
living (IADL), such as difﬁ  culties with management of 
ﬁ  nances (Marson et al 2000), management of medication 
(Cotrell et al 2006), cooking skills (Baum and Edwards 
1993), and communications skills such as using the telephone 
(Loewenstein et al 1995; Ala et al 2005). Although this has 
not been investigated as much as episodic memory training, 
some recent studies aimed to evaluate the impact of cogni-
tive training on IADLs, tapping into procedural learning 
processes. Zanetti and colleagues (2001) obtained positive 
results (ie, a signiﬁ  cant time reduction to carry out the task) 
in a controlled study involving the training of 13 basic and 
instrumental activities of daily living, and these results 
were essentially obtained by encouraging the participants 
to carry out the task, by modeling the task and by provid-
ing the patients with cues, reinforcement, as well as verbal 
and nonverbal prompts. However, this intervention was not 
tailored to the participants’ needs. A case study, such as one 
conducted by Lekeu and colleagues (2002), may thus meet 
the patients’ needs, by targeting a signiﬁ  cant task for the 
participant. The intervention of Lekeu and colleagues (2002) 
involved the EL and SR techniques, and was successful in 
teaching two patients with mild AD to use their cell phone. 
According to the authors, this success could be attributed to 
spare procedural memory in the two patients. Despite a small 
sample size, this study introduces the possibility for patients 
with mild AD to effectively use EL and SR techniques to 
learn or relearn IADLs.
Impairments in IADLs are important in AD, and the pro-
ﬁ  les of difﬁ  culties presented in early AD are heterogeneous 
(Bier et al 2006). Besides, the literature on cognitive training 
suggests that the beneﬁ  ts obtained following the intervention 
do not transfer to untrained tasks (Carney et al 1999; Cicerone 
et al 2000; Davis et al 2001). This underlines the importance 
to train relevant activities in each AD patient. In summary, 
some authors had already reported the efﬁ  cacy of some learn-
ing methods in individualized cognitive training programs 
for AD. However these efﬁ  cacy data were based only on a 
few studies (Adam et al 2000; Lekeu et al 2000; Clare et al 
2001; Bier et al 2008). Therefore, the principal goal of the Neuropsychiatric Disease and Treatment 2008:4(5) 989
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present study was to assess the preliminary efﬁ  cacy of an 
individualized cognitive training program using the EL and 
SR techniques to relearn forgotten IADLs in mild AD. As a 
secondary goal, the present study was also designed to docu-
ment the tolerability of the intervention in the patients and 
caregivers, since the burden of such an intervention has not 
yet been systematically assessed. The heterogeneity of AD 
patients’ cognitive proﬁ  les, the variability of their functional 
needs and the goals of the present study support the choice of 
the case report as a relevant design for conducting the pres-
ent research work. We thus performed a multiple-baseline 
across-subjects case report study.
Ethical considerations
The study was approved by the Ethics and Research Com-
mittee at Laval University (CÉRUL). Before entering into the 
study, patients and their caregivers were fully informed about 
the project and the risks of participating in it. They signed 
an informed consent that was approved by the CÉRUL. All 
nominative data were kept strictly conﬁ  dential by coding of 
all documents.
Case A
Participant A was a 66-year-old man with 20 years of formal 
education. He was a priest, and he had taught philosophy in 
a college. At the time of the study, he had been retired for 
7 years. He lived with a female friend who agreed to par-
ticipate in the study as the principal caregiver. The patient 
and the caregiver were recruited at the Alzheimer Society 
(Quebec City section) during the summer of 2007 follow-
ing a short presentation given by the ﬁ  rst two authors of 
the present paper. Participant A had a familial history of 
AD, as his father and brother had been both diagnosed with 
the disease. The medical records of Participant A revealed 
that he had AD, and did not present other neurological, 
psychiatric, vascular, or systemic disorder known to alter 
cerebral or cognitive integrity. At the time of the screening 
evaluation, Participant A did not have a current or previous 
history of alcohol or substance abuse. At the time of his 
involvement in this study, Participant A was taking donepezil 
(7.5 mg per day) since March 2007 and citalopram (10 mg 
per day) since the beginning of August 2007. He was thus 
stabilized on donepezil for more than three months when the 
study began, but was on citalopram 10 mg per day since 16 
days when he was assessed at baseline. When the cognitive 
training started, Participant A was still on donepezil (same 
dosage than baseline) and was also taking citalopram (10 mg 
per day) since 37 days. He remained on donepezil (7.5 mg 
per day) and citalopram (10 mg per day) up until the end 
of the study.
Screening (diagnostic) evaluation 
and results
A neuropsychological assessment was ﬁ  rst conducted at the 
participant’s home over two periods of 1 and a half hours, in 
order to assess cognitive functions and to determine which 
IADL could be trained. The diagnostic battery included the 
following tests administered to the patient: the Mini-Mental 
State Examination (MMSE) (Folstein et al 1975), Dementia 
Rating Scale-2 (DRS-2) (Mattis 2001), California Verbal 
Learning Test-2 (CVLT-2) (Delis et al 2000), Lexical and 
Semantic Fluency Tasks (Consortium of Montreal and 
McGill universities: Canadian Study of Health and Aging 
1996), Boston Naming Test-30 item-version (BNT) (Kaplan 
et al 1983), Tower of London (ToL) (Culberston and Zillmer 
2000), Trail Making Test (TMT) (Delis et al 2000), and Clock 
Drawing Test (CDT)-Command and Copy (Rouleau et al 
1992; Tuokko et al 1992). The Neuropsychiatric Inventory 
(NPI) (Cummings et al 1994) and the Disability Assess-
ment for Dementia (DAD) (Gélinas and Gauthier 1994) 
were completed with the caregiver per the administration 
manual of the scale. The DAD is a scale designed to assess 
functional ability in community residing individuals with 
dementia. Functional ability is measured through the assess-
ment of basic, instrumental and leisure activities in various 
sections: hygiene, dressing, undressing, continence, eating, 
meal preparations, telephoning, going on an outing, ﬁ  nance, 
correspondence, medications, leisure and housework. In each 
section, intentions and actual actions are assessed separately. 
The scoring is dichotomic (Yes: 1 or No: 0) with the possibil-
ity of nonapplicable (N/A) responses. The total maximum 
score is 46 (with 0 N/A). The authors of the scale proposed a 
conversion of the scores into percentage (manual of the scale; 
Gélinas and Gauthier 1994). Good inter-rater (ICC = 0.95) 
and test-retest reliability (ICC = 0.96) as well as good internal 
validity (α = 0.96) have been established (Gélinas and Auer 
1996). This instrument allowed the selection of a problematic 
IADL in each participant.
The screening evaluation (see Table 1) revealed that 
Participant A was impaired in all the cognitive domains 
assessed. He had a MMSE score of 19, which is indicative of 
mild-to-moderate dementia per the normative data of Bravo 
and Hébert (1997). Relative to his age and education-matched 
cohort, Participant A’s score on the DRS-2 fell in the severely 
impaired range. All the CVLT scores of Participant A were 
below −2.5 standard deviations, revealing severe amnesia. Neuropsychiatric Disease and Treatment 2008:4(5) 990
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Participant A also presented significant impairments in 
semantic memory and language (as measured by the ﬂ  uency 
tasks and the BNT), in executive functions (as measured by 
the ToL, TMT – Number-Letter switching condition and the 
Clock drawing [Command condition]), in visual tracking 
(as measured by the ﬁ  rst three conditions of the TMT), and 
in visuo-construction (as measured by the Clock Drawing 
Test [Copy and Command conditions]). The NPI revealed the 
presence of dysphoria, anxiety, apathy, euphoria, and aberrant 
motor behavior. Participant A had difﬁ  culties with ﬁ  nances, 
Table 1 Results of the cognitive and clinical assessments at screening
Cognitive domains/Tests Participant A   Participant B
 Raw  score AEMSS* score Raw score AEMSS score
Global cognitive functioning
DRS-2
Total score (max. 144) 108 0 119 1
Raw scores Z scores Raw scores Z scores
MMSE 19 −3.0 25 −1.79
Total score (max. 30)
Episodic memory
CVLT (French version)
List A – Sum of trials 1 to 5 17 −2.50 26 −1.6
List B – Immediate recall 0 −3.0 2 −2.0
List A – Short term free recall 0 −2.5 0 −2.5
List A – Short term cued recall 3 −3.0 2 −3.0
List A – Delayed free recall 0 −3.0 0 −3.0
List A – Delayed cued recall 0 −3.0 2 −3.0
Recognition – True positives 8 −3.0 15 0.5
Recognition – False positives 17 −3.0 19 −3.0
Semantic memory/Language
BNT (30-item version) 21 −2.0 15 −2.0
Verbal ﬂ  uency
Phonemic 17 −2.52 27 −1.59
Semantic 9 −2.02 8 −2.02
Executive functions
Tower of London
Total move score 145 −2.67 27 0.8
Trail Making Test
Visual scanning 73 −3.0 36 −1.0
Number sequencing 150 −3.0 27 1.33
Letter sequencing 150 −3.0 21 1.33
Number-Letter Switching 240 −3.0 91 0.67
Motor speed 118 −3.0 20 1.0
Clock Drawing Test
Copy (max. 10) 5 −3.0 90
Free drawing (max. 10) 6 −2.63 10 0.95
Activities of daily living
DAD (%) 73% 86%
Neuropsychiatric symptoms 18 3
NPI (max. 144)
Note: *Age and Education Corrected Scaled Score.
Abbreviations:Neuropsychiatric Disease and Treatment 2008:4(5) 991
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correspondence, telephoning and going on an outing, and also 
with hygiene and dressing, as assessed by the DAD. Participant 
A thus presented cognitive, affective and behavioral altera-
tions typically reported in AD, and he indeed met the National 
Institute of Neurological and Communicative Disorders and 
Stroke and the Alzheimer’s Disease and Related Disorders 
Association (NINCDS-ADRDA) criteria for probable AD 
(McKhann et al 1984). Considering the difﬁ  culties presented 
by the patient and the needs regarding IADLs expressed by his 
caregiver, we selected the utilization of the voice mail as the 
task to be trained. The caregiver informed the research team 
that the participant panicked every time he tried to use his voice 
mail. The caregiver and the patient wanted the utilization of the 
voice mail to be retrained mainly for security reasons.
Evaluation of efﬁ  cacy and tolerability
The performance on the task to be trained was assessed by a 
direct measure of training (DMT). In order to adapt the train-
ing program to individual differences and needs, the form 
of the DMT was different in each participant. The DMTs 
were created from existing functional scales, chosen for their 
good psychometric qualities (Moore et al 2007) and their 
relevance to the task to be trained. The DMT of Participant 
A was adapted from the ADL Situational Test (Skurla et al 
1988). This instrument contains four tasks (see Table 2). Each 
task has several items, and every item is scored according 
to the degree of assistance needed: 4 = completes the task 
independently; 3 = requires verbal prompting; 2 = requires 
verbal and visual prompting; 1 = requires verbal, visual and 
physical prompting; and 0 = does not complete the task. In 
the study of Skurla (1988), the ADL Situational Test was 
correlated with a measure of global cognitive functioning 
especially designed for the evaluation of AD, the Clinical 
Dementia Rating Scale (CDRS) (Hugues et al 1982). The 
telephoning situation task was adapted to create the DMT 
of Participant A. Some of the 11 original items of the 
task were integrally kept (eg, “Picks up the receiver 
before dialing”), some were adapted (eg, “Attempts to 
use phone book” became “Look at the information card 
to ﬁ  nd the number to dial”), and some items were added 
(eg, “Listen to the options”). The DMT of Participant A thus 
contained 16 items. The administration and scoring procedures 
were similar to those used in the original ADL Situational 
Test. The total score was reported in percentage (maximum 
possible raw score = 64).
The general cognitive functioning was assessed by the 
DRS-2. This scale is valid and reliable to detect AD (Jurica 
et al 2001), is sensitive to cognitive deterioration associated 
with dementia over time (Salmon et al 1990), and indicates 
severity of dementia, (Shay et al 1991; Monsch et al 1995; 
Stuss et al 1996). The everyday memory functioning was 
assessed by the Rivermead Behavioral Memory Test (RBMT). 
The RBMT was developed to monitor change following 
treatment for memory disorders (Lezak 2004). The RBMT-
four alternative forms permit to follow the evolution of the 
performance while controlling for practice effects. Three ways 
Table 2 Description of the baseline instruments
Instruments/Domain assessed Sub-scales Validity data Reliability data
ADL Situational Test (Skurla et al 
1988)/Functional living skills
Dressing for a cold and rainy day; 
Making a cup of coffee; Purchasing 
a snack and gloves; Telephoning 
the pharmacy
Total score was correlated with 
CDRS (r = 0.60, p  0.05)
None provided
DAFS (Loewenstein et al 1989)/
Functional living skills
Time orientation; communication 
abilities; transportation; ﬁ  nancial 
skills; shopping skills; eating skills; 
dressing/grooming skills.
Performance of AD patients 
correlated with the BDRS 
(r = −0.59, p  0.01)
Inter-rater reliability of 0.93; 
Test-retest reliability from 0.72 
to 0.91
DRS-II/General cognitive functioning Attention; Initiation/Perseveration; 
Construction; Concepts; Memory
Score correlated with MMSE 
(r = 0.82)
Test-retest reliability of 0.97 for 
the Total Score
RBMT/Everyday memory functioning First and Second Name; Belonging; 
Appointment; Pictures; Story; 
Faces; Route; Message; Orientation 
and Date
Score correlated with observed 
memory lapses (r = −0.71 for 
the Screening Score and −0.75 
for the standardized Proﬁ  le 
Score, p  0.001)
Inter-rater reliability of 1.00; 
parallel-form reliability from 0.83 
to 0.88 for the standardized Proﬁ  le 
Score; Test-retest reliability of 0.85 
for the Proﬁ  le Score
DQoL/Quality of life Self-esteem; Positive affect/
humour; Negative affect; Feelings 
of belonging; Sense of aesthetics
The negative affect scale 
correlated with the Geriatric 
Depression Scale (r = 0.64)
Internal consistency ranging from 
0.67 to 0.89; Test-retest reliability 
ranging from 0.64 to 0.90
Abbreviations:Neuropsychiatric Disease and Treatment 2008:4(5) 992
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of scoring are possible: the raw score, the standardized proﬁ  le 
score and the screening score. This instrument has good validity, 
perfect inter-rater reliability, good parallel-form reliability 
and good test-retest reliability (Wilson et al 1989). Finally, 
the Dementia Quality of Life instrument (DQoL) is a self-
reported measure on the quality of life designed for patients 
with dementia presenting an MMSE 12. This instrument has 
moderate to high internal consistency between the different 
scales and good convergent validity and test-retest reliability 
(Brod et al 1999; Schölzel-Dorenbos et al 2007).
The patient’s tolerability was assessed using the atten-
dance at the different training sessions, the attendance and 
regularity of the practices (as assessed by the practice journal) 
and the feedback provided by the participant and his caregiver 
(also documented in the practice journal). The caregiver’s 
tolerability was assessed using his feedback, the observation 
of his ability to practice the task with the participant, and by 
his attendance at the patient’s practice sessions (as assessed 
by the practice journal).
Establishment of the baseline level 
of performance and general procedure
After the screening evaluation, a baseline evaluation was 
carried out using the DMT, at three different moments, over 
a 2-week period, to establish a reliable baseline level of 
performance before the introduction of the cognitive training. 
The number of three baseline assessments was chosen for 
best reliability as a minimum of two baseline assessments is 
usually required (Levine and Downey-Lamb 2005). The other 
baseline evaluations were realized in order to assess the general 
cognitive functioning (DRS-2), everyday memory functioning 
(RBMT), and quality of life (DQoL). Then, the chosen task was 
trained during two sessions per week for four weeks, during 
which EL and SR techniques were applied. The DMT was thus 
administered at baseline, at the end of each training sessions, 
in order to follow the progression of learning, and at the two 
follow-ups. The other instruments of the baseline evaluation 
(RBMT-alternate forms, DQoL) were re-administered at the 
end of the training and at the two follow-ups performed one 
(FU 1) and ﬁ  ve (FU 2) weeks after completion of the training 
program. Because it has only one alternative form, the DRS-2 
was re-administered only at the ﬁ  rst follow-up.
Cognitive training
The intervention was implemented at week 2 following 
the third baseline assessment on the DMT (see Figure 1). 
Participant A was trained to use his voice mail. The interven-
tion consisted of two sessions per week, each lasting from 
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45 minutes to 1 hour. This training was delivered by a PhD 
candidate (ST) supervised by a neuropsychologist (MS). In 
order to ensure that the participant did not commit errors 
during the learning (errorless learning paradigm), decreasing 
degrees of assistance were provided, adapted to the patient’s 
performance. The four levels of assistance were: 1) the assistant 
carried out the task in front of the participant; 2) the assistant 
named each step of the task to be carried out and the partici-
pant executed each of these steps; 3) the participant named all 
the steps of the task and carried out these steps with the help 
of the assistant, if needed; 4) the participant carried out the 
task independently. In order to facilitate the retrieval of infor-
mation, expanded delays (30 seconds, 1 minute, 2 minutes, 
4 minutes and 8 minutes) were inserted between each correct 
realization of the task (spaced retrieval paradigm). When an 
incorrect performance occurred, a return to the previous time 
interval was made, and the previous level of assistance was 
restored (for example: if at the 4-minute interval, assistance 
3 was given and an error occurred, the next trial was at an 
interval of 2 minutes and assistance 2 was given) . At the next 
successful trial, the interval time was increased once again, 
but only by half of the next time interval initially planned. 
The participant was asked to practice the task at least three 
times a week outside of the cognitive training program, under 
the supervision of his caregiver. The caregiver was trained to 
use the cognitive training techniques by the PhD candidate 
and a manual including information on memory systems, AD, 
learning techniques and their application was also provided. 
The caregiver was asked to ﬁ  ll out a practice journal, in order 
to provide information and assistance as needed, to verify the 
tolerability of the training program, and also to ensure that the 
practices took place each week of the program. The caregiver 
of Participant A mentioned that she continued to practice with 
the patient, one to two times per week, during 3 weeks, after 
the end of the intervention phase.
Results of training
Figure 1 illustrates the scores obtained on the DMT by 
Participant A at each baseline measurement and at every 
training session. The vertical line on Figure 1 represents 
the onset of training. Table 3 presents the raw data and 
percentages obtained on the DMT by Participant A at each 
baseline measurement and at every training session as well 
as at Follow-ups 1 and 2. Table 4 indicates the results of the 
Participant A at baseline, post-intervention and at follow-ups 
on the DRS-2, the RBMT, and the DQoL.
Participant A performed with a mean of 57.3% on the 
baseline measures. The training was introduced when his 
performance was in decline (see Figure 1 and Table 3). His 
performance improved from 62.5% to 75.0% with the introduc-
tion of the intervention, and showed a constant amelioration 
during the training program. Participant A completed the train-
ing sessions with a performance of 93.7%. His best performance 
was of 96.9% at training session #6. He was able to maintain his 
new skill over a period of ﬁ  ve weeks, since his performances at 
Follow-ups 1 and 2 reached, respectively, 90.6% and 89.1% on 
the DMT (the FU results are not shown on Figure 1). In order 
to strengthen this visual analysis, we calculated the effect size 
of the intervention using the Common Language Effect-Size 
(CLES) statistic (McGraw and Wong 1992). This statistic is 
comparable to Cohen’s d, and generates a Z score for the dif-
ference between the two means in case reports. This Z score is 
then converted to a probability from a Z table: ZCL =  (M1 – M2)/ 
√ (Var1 + Var2) (Parker and Hagan-Burke 2007). We contrasted 
the baseline score (M1) with the scores of the intervention and 
follow-up phases (M2). Participant A obtained the following 
results: M1 = 57.30, M2 = 88.42, Var1 = 108.64, Var2 = 32.97 
and ZCL = −31.12/11.19 = −2.61, which is a 0.9955 probability 
in a normal Z distribution. Therefore, a 99.55% chance exists 
that any treatment or follow-up scores will be higher than any 
baseline scores. His scores on the DRS-2 and on the DQoL 
remained relatively stable. However, scores on the RBMT 
ﬂ  uctuated through the evaluations (see Table 4).
The training program was well tolerated by the participant 
and his caregiver since they did not miss any evaluations, 
training sessions or follow-ups. Participant A did not express 
signs of fatigue or overwhelming anxiety or distress in any 
Table 3 Results of participants A and B on the direct measure of 
training at each training session
Sessions Participant   A Participant B
Baseline 1 29/64 (45.3%) 5/12 (41.7%)
Baseline 2 41/64 (64.1%) 6/12 (50.0%)
Baseline 3 40/64 (62.5%) 6/12 (50.0%)
Baseline 4 n/a 6/12 (50.0%)
Training session 1 48/64 (75.0%) 5/12 (41.7%)
Training session 2 52/64 (81.3%) 6/12 (50.0%)
Training session 3 51/64 (79.7%) 8/12 (66.7%)
Training session 4 56/64 (87.5%) 6/12 (50.0%)
Training session 5 55/64 (85.9%) 12/12 (100.0%)
Training session 6 62/64 (96.9%) 9/12 (75.0%)
Training session 7 60/64 (93.7%) 9/12 (75.0%)
Training session 8 60/64 (93.7%) 11/12 (91.7%)
Training session 9 n/a 9/12 (75.0%)
Follow-up 1 58/64 (90.6%) 9/12 (75.0%)
Follow-up 2 57/64 (89.1%) 10/12 (83.3%)Neuropsychiatric Disease and Treatment 2008:4(5) 994
Thivierge et al
parts of the intervention. The caregiver did not report an 
increase of neuropsychiatric symptoms in Participant A. The 
caregiver also mentioned that she witnessed amelioration on 
the trained task as the cognitive intervention progressed. The 
caregiver well understood and correctly applied the principles 
of EL and SR following her training with the ﬁ  rst author of 
the present paper. She was able to practice the task with the 
participant, as demonstrated by the practice journal and the 
feedback she provided to the ﬁ  rst author (ST). She did not 
complain about the time she had to devote to the study, and 
did not report an increase of burden.
Case B
Participant B was a 68-year-old man with 17 years of formal 
education. He had been a civil engineer before his retirement. 
At the time of his involvement in the study, he had been retired 
Table 4 Results of participants on the DRS-2, RBMT, and DQoL
Participant   A
Baseline Post-intervention Follow-up 1 Follow-up 2
DRS-2
Total score (max. 144) 108 107
Attention (max. 37) 33 N/A 34 N/A
Initiation/Perseveration(max.37) 25 21
Construction(max. 6) 6 6
Conceptualization (max. 39) 33 36
Memory (max. 25) 11 10
RBMT
Standardised proﬁ  le score (max. 12) 5 4 0 5
Screening score (max. 24) 2 1 0 1
DQoL
Total score (max. 145) 130 129 129 130
Self-esteem (max. 20) 19 19 17 18
Positive affect/humour(max. 30) 29 28 28 28
Negative affect (max. 55) 46 49 51 49
Feelings of belonging (max. 15) 13 14 13 14
Sense of aesthetics (max. 25) 23 19 20 21
Participant B
DRS-2
Total score 119 123
Attention 36 37
Initiation/Perseveration 29 N/A 32 N/A
Construction 5 6
Conceptualization 37 32
Memory 14 16
RBMT
Standardized proﬁ  le score 6 3 9 5
Screening score 0 0 3 3
DQoL
Total score 112 106 104 110
Self-esteem 17 17 16 20
Positive affect/humor 24 23 24 26
Negative affect 48 46 44 42
Feelings of belonging 10 10 9 12
Sense of aesthetics 13 10 11 10
Abbreviations:Neuropsychiatric Disease and Treatment 2008:4(5) 995
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for 14 years. He lived alone in the community, but his son 
agreed to get involved in the study as the principal caregiver. 
Participant B had a familial history of AD since his father had 
been diagnosed with the disease before dying. The medical 
records of Participant B revealed that apart from AD, he did 
not present other neurological, psychiatric, vascular, or sys-
temic disorder known to alter cerebral or cognitive integrity, 
and he did not have a current or previous history of alcohol 
or substance abuse. At the time of his involvement in this 
study, Participant B was taking galantamine 16 mg per day 
since at least three months.
Screening (diagnostic) evaluation
and results
Participant B underwent the same neuropsychological and 
clinical assessment as Participant A (see Table 1). He had a 
MMSE total score of 25, indicating mild dementia (per age and 
education adjusted score; Bravo and Hébert 1997). Relative to 
his age and education-matched cohort, his score on the DRS-2 
fell in the severely impaired range. His performance on the 
CVLT revealed severe episodic memory problems. Participant 
B also presented impairments in semantic memory and lan-
guage (as measured by the BNT and the ﬂ  uency tasks). How-
ever, executive functions (as measured by the ToL, the TMT, 
and the CDT), were still in the normal range at the time of the 
screening evaluation. Participant B presented mild symptoms 
of euphoria and disinhibition on the NPI. The DAD revealed 
problems with the utilization of the telephone and the manage-
ment of ﬁ  nances, correspondence, medication, and housework. 
Participant B thus met the NINCDS-ADRDA diagnostic 
criteria for probable AD (McKhann et al 1984). Taking into 
account the difﬁ  culties presented by the patient as expressed 
by his caregiver, we decided to select the management of the 
messages from his answering machine as the task to be trained. 
Prior to the training, Participant B was able to correctly note 
his messages, but he did not erase them on the answering 
machine, and kept writing notes about old and new messages. 
As a result, he was overwhelmed, confused and stressed by the 
high number of notes he had written, and by the presence of 
several new and old messages on his answering machine. He 
never remembered that he had already listened to a message 
and that he had already responded to this message, and could, 
for example, call back two or three times the same person in 
relation to a message left on his answering machine.
Evaluation of efﬁ  cacy and tolerability
The performance on the task to be trained was assessed by a 
DMT.  The DMT of Participant B was derived from the Direct 
Assessment of Functional Status (DAFS) (Loewenstein et al 
1989). This instrument assesses the functional performance 
in seven domains (see Table 2). For each individual item of 
a subscale, a score of 0 (incorrect performance) or 1 point 
(correct performance) is given. This instrument showed high 
interrater and test-retest reliability, and the performance of 
AD patients on the DAFS signiﬁ  cantly correlated with the 
Blessed Dementia Rating Scale (BDRS) (Blessed et al 1968) 
in the study of Lowenstein and colleagues (1989). The DMT 
of Participant B was adapted especially from the ‘Using the 
telephone’ task of the DAFS to assess the capacity to man-
age the messages on the answering machine. Twelve items 
tapping into this domain were created. Participant B was thus 
evaluated on his ability to manage three types of message: 
1) an appointment; 2) news; 3) or something he has to do in 
the future (such as calling somebody during the week). As 
with the DAFS, 0 or 1 point was granted for each item. In 
order to facilitate comparisons between Participants A and 
B, the total score of the DMT of Participant B was reported 
in percentage (maximum possible raw score = 12).
In addition, Participant B was administered, as was Par-
ticipant A, with the DRS-2, the RBMT and the DQoL (see 
Table 2). The tolerability was assessed in a similar manner 
in Participants A and B.
Establishment of the baseline level
of performance and general procedure
The baseline evaluation was carried out, after the screening 
evaluation, at four different moments, over a 4-week period, 
on the DMT (see Figure 1 and Table 3). The other baseline 
evaluations were realized in order to assess the general cogni-
tive functioning, everyday memory functioning, and quality 
of life. Then, the chosen functional task was trained during 
two sessions per week for four weeks, during which EL and 
SR techniques were applied. The instruments of the baseline 
evaluation were re-administered at the end of the training and 
at the 2 follow-ups performed one (FU 1) and ﬁ  ve (FU 2) 
weeks after completion of the training program.
Cognitive training
Participant B was trained to manage the messages from his 
answering machine. The cognitive training was implemented 
at different times for each participant because if the per-
formance of the trained participant increased while the 
performance of the untrained participant remained at the 
baseline level, the amelioration could reasonably be imputed 
to the introduction of the cognitive training (Kazdin 1982; 
Barlow and Hersen 1984). Therefore the cognitive training of Neuropsychiatric Disease and Treatment 2008:4(5) 996
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Participant B started at week 4, following the fourth baseline 
assessment on the DMT. Except for the DMT, the same cogni-
tive training procedures as Participant A were implemented 
for Participant B. However, the caregiver did not continue to 
practice with Participant B following the end of the interven-
tion phase as the Participant A’s caregiver did.
Results of training
Participant B had a mean performance of 47.9% at baseline. 
Although he was stable on the last three baseline measure-
ments per the DMT (see Figure 1 and Table 3), his perfor-
mances ﬂ  uctuated throughout the training sessions. However, 
he reached a perfect score at training session #5 (100.0%). 
A ninth training sessions was added because of his ﬂ  uctuating 
performances on the DMT. He completed the training phase 
with a score of 75.0% on the DMT. He also maintained his 
new skill, as demonstrated by the percentages he obtained 
at the follow-ups, (ie, 75.0% at Follow- up 1 and 83.3% at 
Follow-up 2 (the FU results are not shown on Figure 1). As for 
Participant A, we calculated the effect size of the intervention 
with the CLES statistic. Participant B obtained the following 
results: M1 = 47.92, M2 = 73.26, Var1 = 17.22, Var2 = 227.23 
and ZCL = −25.34/15.63 = −1.62, which corresponds to a 
0.9474 probability in a normal Z distribution. Therefore, a 
94.74% chance exists that any treatment or follow-up scores 
will be higher than any baseline scores. The scores on the 
DRS-2 and the DQoL were relatively stable. However, the 
performances on the RBMT ﬂ  uctuated (see Table 4).
Participant B well tolerated the training program. He did 
not miss any evaluations, training sessions or follow-ups. Par-
ticipant B did not express signs of fatigue or overwhelming 
anxiety or distress during any parts of the intervention and 
his caregiver did not report an increase of neuropsychiatric 
symptoms. The caregiver also mentioned that he witnessed 
amelioration on the trained task as the cognitive training 
progressed. The caregiver was always present when it was 
necessary. The principles of the learning techniques were 
well understood and were also applied appropriately by the 
caregiver, and as a result, the caregiver regularly practiced 
the task to be trained with the participant, as demonstrated 
by the practice journal and the feedback he provided to the 
ﬁ  rst author of the study (ST). Participant B’s caregiver did 
not report an increase in burden, and he also did not mention 
that the study was too time-consuming.
Discussion
This case report study demonstrated that it is possible, for 
patients with AD, to relearn forgotten IADLs using the EL 
and SR techniques. Both participants improved considerably 
on the DMT, and reached perfect or nearly perfect 
performances during training (Participant A = 96.9%; and 
Participant B = 100%). In addition, the results of the effect 
size calculations provided an objective measure of the inter-
vention’ strength (Parker and Hagan-Burke 2007). While the 
performance of Participant A improved with the introduction 
of the cognitive training, the performance of Participant B 
(still untrained at the time) remained relatively stable, indicat-
ing that the performance of Participant A was not improved 
or inﬂ  uenced by extraneous factors (eg, maturation, history 
or testing) (Backman et al 1997; Kazdin 2002). Moreover, the 
proposed intervention was well tolerated by both participants 
and their caregivers. To our knowledge, tolerability has not 
been formally measured in similar case studies.
Although Participant B was in a milder stage of AD, he 
did not ameliorate the skill to relearn right after the intro-
duction of the cognitive training; instead his learning curve 
ﬂ  uctuated, and he completed training with a score below that 
of Participant A. This can possibly be explained by the fact 
that the practices with the caregiver of Participant B started 
later and were less frequent than those of Participant A, as 
revealed by the practice journal. Participant A started to 
practice with his caregiver in the ﬁ  rst week of the training 
phase, and he practiced the skill three to four times per week 
with his caregiver, whereas Participant B began to practice 
with his caregiver in the second week of the training phase, 
and he only received two to three practices per week. The 
caregiver for Participant B was his son, and did not live with 
the patient as did Participant A’s caregiver. Moreover, it is 
possible that the DMT of Participant A was more sensitive 
to the improvement since it allowed scoring to be graded 
from 0 to 4 points according to the assistance required by 
the participant for a correct realization of each part of the 
activity. The pass or fail mode of scoring on Participant B’s 
DMT might not have reﬂ  ected the range of change between 
a failed performance and a successful one.
The cognitive training did not increase general cognitive 
functioning, everyday memory functioning and quality of 
life as measured by, respectively, the DRS-2, the RBMT, and 
the DQoL. In both participants, there were some ﬂ  uctuations 
in the results of the RBMT, but there was no ﬂ  uctuation 
in the results of the memory subscale of the DRS-II. The 
ﬂ  uctuating RBMT scores of Participants A and B did not 
indicate an overall amelioration or deterioration in everyday 
memory performance. It is interesting to note that these ﬂ  uc-
tuations were not found in a longitudinal analysis of memory 
functioning in patients with schizophrenia assessed with the Neuropsychiatric Disease and Treatment 2008:4(5) 997
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RBMT at baseline, 9 months and 18 months later (Tyson 
et al 2005). This absence of variation in the RBMT scores in 
another clinical population suffering from a nondegenerative 
disorder, combined with the good parallel-form reliability 
and good test-retest reliability (Wilson et al 1989) established 
for the RBMT, strongly suggest that these ﬂ  uctuations could 
perhaps be due to the characteristics of the AD population, 
to the cognitive training, or both. However, without a control 
group, it is difﬁ  cult to determine whether the ﬂ  uctuations 
were caused by the cognitive training or by natural progres-
sion of AD in which ﬂ  uctuations are frequently reported 
(Bradshaw et al 2004).
Although this kind of cognitive training has not been 
largely investigated in previous studies, the present results 
are consistent with some ﬁ  ndings reported in the literature. 
Based on the preservation of procedural memory in AD, 
Zanetti and colleagues (2001) and Lekeu and colleagues 
(2002) demonstrated that it is possible to have functional 
gains following the cognitive training of ADL in patients 
with AD. However, Zanetti and colleagues (2001) concluded 
that their intervention was effective on the basis of a decrease 
in the total completion time for the realization of the 13 ADLs 
trained. Of these 13 ADLs, there were basic (eg, dressing) 
and instrumental (eg, using the telephone) ADLs. Since the 
authors did not give the individual completion time registered 
for each ADL or the completion time registered for the basic 
ADLs and the instrumental ADLs, it is impossible to deter-
mine the contribution of each activity in the improvement 
obtained following the intervention. It is possible that the 
intervention had little effect on the instrumental ADLs. In 
addition, a decrease in the time required to complete a task 
doesn’t mean that the patient improved his ability to correctly 
perform the activity. These are important ﬁ  ndings but of little 
clinical utility. On the contrary, the present study demon-
strated that AD patients can improve their ability to realize 
an IADL. The intervention program is one among the few 
that have been tailored to the difﬁ  culties presented by each 
patient, as expressed by his caregiver. This last particularity 
is of crucial importance for the clinical application of the 
intervention. The gains obtained by cognitive training are 
speciﬁ  c to the trained material because the improvement did 
not generalize to the cognitive functions measured.
In a recent study assessing the efﬁ  cacy of a cognitive 
training program for AD patients receiving cholinesterase 
inhibitors, Loewenstein and colleagues (2004) argued that 
cognitive training programs should focus speciﬁ  cally on 
the training of functional tasks, rather than simply targeting 
general theoretical cognitive constructs. These authors found 
that their participants did not improve their performance on 
the neuropsychological tests unrelated to the training. These 
results are similar to those obtained in the current study. 
Altogether these ﬁ  ndings should prompt the development 
of cognitive intervention programs that will allow direct 
amelioration in the real life activities of AD patients. The 
proposed intervention required few sessions to acquire and 
retain new learning, which have clinical application in the 
context of AD rehabilitation. To our knowledge, only a very 
limited number of published studies have already reported 
such an improvement in learning abilities following a 4-week 
intervention. Finally, the present study has the particularity 
that it required the caregiver’s involvement for the training 
phase. The good understanding and participation of the care-
givers in this study indicated that they can collaborate in the 
cognitive rehabilitation of their relatives suffering from AD. 
This is an important ﬁ  nding given the augmentation of cost 
restrictions in health institutions and management.
This study however presents some limitations. First of 
all, no improvement in quality of life was found. Such an 
improvement might have provided support to the fact that the 
intervention met functional needs. However, a lack of sensitivity 
of the tool used herein might explain the results. Although 
the multiple-baseline across subjects design is generally con-
sidered to be the most robust among the single case designs 
(Levine and Downey-Lamb 2005), it nevertheless has some 
limits. This design does not provide much evidence regard-
ing the participant’s characteristics that may interact with or 
moderate the effects of the intervention. In addition, it does 
not tell much about the generality of ﬁ  ndings (Kazdin 2002). 
For example, the results might only be generalized to patients 
with caregivers showing particular personal features such as 
low burden, high motivation, and good learning skills. Another 
limitation is that all phases of this study were realized by the 
same individual (the ﬁ  rst author of the study), allowing the 
introduction of an experimenter bias. However, all the assess-
ments were conducted in a standardized manner, strictly fol-
lowing the administration and scoring instructions of the test 
manuals. In addition, this situation replicates the conditions 
of cognitive training in clinical settings where, most of the 
time, only one clinician will administer the training. The fact 
that Participant A was on citalopram for only 16 days when 
he was tested at baseline could potentially represent a threat to 
internal validity. Indeed, one might argue that the improvement 
on the task could be due to the positive effects of citalopram. 
However, the results of recent studies conducted in healthy 
adults receiving 10 to 40 mg per day of citalopram (Rose et al 
2006; Paul et al 2007), and in patients with mild-to-moderate Neuropsychiatric Disease and Treatment 2008:4(5) 998
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AD receiving a mean dose of 35 mg per day of citalopram 
together with a cholinesterase inhibitor (Caballero et al 2006) 
showed that citalopram had no impact on several measures 
of cognition at short (few weeks) and long-term (annual) 
time intervals. Therefore it is unlikely that the improvements 
registered by Participant A on the trained task were due to 
citalopram, especially given that his performance did not 
improve on the DRS-2. The amelioration on the trained task 
was measured using a different DMT for each participant. The 
DMTs were adapted from existing functional scales designed 
to speciﬁ  cally assess the amelioration of a forgotten IADL for 
each participant. Even though these instruments were adapted 
from relevant performance scales with good psychometric 
properties, we cannot presume that the modiﬁ  cations we intro-
duced did not modify their validity and reliability. However, 
the fact that the caregiver’s comments (in the practice journal) 
mirrored the results found on the 2 DMT suggests that these 
instruments had some validity. Despite these limitations, the 
inclusion of such measures allowed the training and the direct 
assessment of the performance of IADLs that were signiﬁ  cant 
for the two participants. This is an original contribution with 
a strong clinical relevance.
In conclusion, this investigation supports the tolerability 
and preliminary efﬁ  cacy of a new cognitive training program 
using EL and SR techniques designed to respond speciﬁ  -
cally to the needs of AD patients. However, these promising 
results will have to be replicated in future case studies or 
in a more robust research design such as a single/multiple 
subject design including a comparison with control tasks 
(Backman et al 1997). Nevertheless, interventions such as the 
one conducted in this study are needed in order to maintain 
or enhance AD patient’s autonomy in daily living.
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